A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study

A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study

Background: Biliary tract cancer (BTC) is a heterogenous collection of biliary tract cancer at different primary sites, and the prognosis of advanced BTC is dismal. Systemic chemotherapy with gemcitabine and cisplatin (GC) has been the reference regimen since 2010. How to improve therapeutic effects...

Full description

Bibliographic Details
Main Authors: Sung-Nan Pei, Chun-Kai Liao, Yaw-Sen Chen, Cheng-Hao Tseng, Chao-Ming Hung, Chong-Chi Chiu, Meng-Che Hsieh, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Kun-Ming Rau
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
advanced biliary tract cancer
bevacizumab
vascular normalization
gemcitabine
response rate
Online Access:https://www.mdpi.com/2072-6694/13/15/3831

Internet

https://www.mdpi.com/2072-6694/13/15/3831

Similar Items